Comparison of Body Weight Change During Contraception With Belara and Yasmin
Status:
Unknown status
Trial end date:
2016-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate different side effect in contraceptive use of two
oral combined contraceptive pills (OCP)in combination of 30 mcg ethinylestradiol/2 mg
chlormadinone acetate (Belara®) and 30 mcg ethinylestradiol/3 mg drospirenone (Yasmin®),
especially body weight change.
Phase:
Phase 4
Details
Lead Sponsor:
Mahidol University
Treatments:
Chlormadinone Acetate Drospirenone Drospirenone and ethinyl estradiol combination Ethinyl Estradiol